Fulgent Genetics, Inc. (FLGT) vs Prime Medicine, Inc. (PRME)
A side-by-side comparison of Fulgent Genetics, Inc. and Prime Medicine, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FLGT
Fulgent Genetics, Inc.
$20.69HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
PRME
Prime Medicine, Inc.
$3.52HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — FLGT vs PRME
growth of $100 · dividends reinvested · last 4yFLGT -38.0% (-11.3%/yr)PRME -79.1% (-32.4%/yr)FLGT compounded faster over this window
FLGT PRME
FLGT vs PRME: by the numbers
- •PRME is the larger company ($636M vs $588M market cap).
- •Both run net losses; FLGT's is the smaller (-26.05% vs -4613.11% net margin).
- •Both shrank revenue over the past five years; PRME's decline was smaller (-2.32% vs -18.66% CAGR).
Metrics side by side
Valuation
| Metric | FLGT | PRME |
|---|---|---|
| P/S ratio | 1.81 | 156.27 |
| P/B ratio | 0.59 | 15.99 |
Profitability
| Metric | FLGT | PRME |
|---|---|---|
| Gross margin | 35.58% | -58.05% |
| Operating margin | -28.23% | -4498.06% |
| Net margin | -26.05% | -4613.11% |
| ROE | -8.42% | -471.98% |
| ROIC | -11.80% | -90.42% |
Growth (annualized)
| Metric | FLGT | PRME |
|---|---|---|
| Revenue CAGR (5Y) | -18.66% | -2.32% |
| Total return CAGR (5Y) | -22.38% | N/A |
Frequently asked
- Which has grown faster, FLGT or PRME?
- Neither grew: over the past five years both shrank revenue, with PRME's decline the smaller — FLGT at a -18.66% CAGR versus PRME at -2.32%.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.